Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum VALEANT PHARMACEUTICALS INTL INC T.VRX

"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."

Bullboard (TSX:VRX)

View:
Comment by w8asecon Nov 07, 2017 5:50pm

RE:Bad news

I wonder what a fair PE multiple is for VRX? - Afterall they are still in the penalty box....but this was a good quarter... hmmmm
Post by Franchuttoon Nov 07, 2017 9:23am

Bad news

Just checking the shorts on https://shortdata.ca/?c=valeant-pharmaceuticals%20international%2C%20inc.-short-sales&sym=VRX.TO , I smell short squeeze as many will have to cover, bringing ...more  
Post by Franchuttoon Nov 07, 2017 7:58am

Earnings

Just feeling kinda sad for the shorts after seeing the results, it might not be too late to recoup losses by changing sides, reminds me musical chair when music stops and the guy you just called dumb ...more  
Post by yrmacon Nov 02, 2017 4:51pm

news

ellesse +.39 cents after hour. Bausch + Lomb And Nicox Announce FDA Approval Of VYZULTA (latanoprostene Bunod Ophthalmic Solution), 0.024% T.VRX | 44 minutes ago First Prostaglandin Analog with one of ...more  
Comment by Ellesseon Nov 02, 2017 3:06pm

RE:News Out on VALEANT PHARMACEUTICALS INTERNATIONAL (T.VRX)

This is crazy.... so far, it was a good news this morning and the stock dropped over 7.00%....
Post by atariguyon Nov 01, 2017 9:18pm

Litigation agreement with Pershing expired today

https://www.sec.gov/Archives/edgar/data/885590/000095010317001353/dp72875_8k.htm
Post by Abruzzoon Nov 01, 2017 12:22pm

Short Covering

If the price stays above $11 USD there might be some short covering. There's a large put option around 55000 for $11 USD for Nov 17.
Post by goldminer4lifeon Nov 01, 2017 10:37am

bottom is in

long to earnings target 18-19
Post by amirpccon Nov 01, 2017 8:53am

Be greedy when others are fearful.

be greedy when others are fearful.   https://www.marketwatch.com/story/valeant-says-its-on-track-to-pay-down-more-than-5-bln-in-debt-ahead-of-goal-2017-10-31?siteid=yhoof2&yptr=yahoo  ...more  
Comment by mtgfree1on Oct 31, 2017 9:33am

RE:RE:Huge debt, hugely overpriced stock

Dream in people , it’s s down she goes story      $9-$11 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities